GADSDEN REPORT
Don't Tread On The Truth
Top Stories

Personalized Cancer Vaccine Shows Promise In Major Trial

Pharmaceutical companies Merck and Moderna reported that an experimental personalized mRNA vaccine, given alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. Read more at DAILY WIRE ›
Read the full story at
DAILY WIRE
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to DAILY WIRE, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Discussion — 0 comments

No comments yet. Be the first.